4-Hydroxy-7-oxo-5-heptenoic acid lactone can induce mitochondrial dysfunction in retinal pigmented epithelial cells

Area of Science:

• Biochemistry
• Cell Biology
• Ophthalmology

Background:

• Docosahexaenoate (DHA) oxidation releases HOHA lactone, a toxic aldehyde.
• HOHA lactone causes RPE cell dysfunction, apoptosis, and angiogenesis.
• CEP derivatives from HOHA lactone adduction are linked to age-related macular degeneration (AMD).

Purpose of the Study:

• Investigate HOHA lactone's impact on mitochondrial function in RPE cells.
• Evaluate the efficacy of histidyl hydrazide (HH) as a scavenger for HOHA lactone.
• Explore therapeutic potential of HH derivatives for eye diseases.

Main Methods:

• Assessed mitochondrial dysfunction markers (ATP, membrane potential, complex activities) after HOHA lactone exposure.
• Measured glutathione (GSH) levels and oxidative stress.
• Tested pyridoxamine and histidyl hydrazide (HH) for HOHA lactone scavenging.
• Examined cytotoxicity of HOHA lactone and protection by HH in ARPE-19 cells.
• Synthesized and tested Nα-acyl L-histidyl hydrazide derivatives.

Main Results:

• HOHA lactone induced mitochondrial dysfunction, decreased ATP and GSH, and increased oxidative stress in RPE cells.
• Pyridoxamine was ineffective, but HH effectively scavenged HOHA lactone.
• HH protected ARPE-19 cells from HOHA lactone-induced cytotoxicity.
• Lipophilic Nα-acyl L-histidyl hydrazide derivatives retained protective efficacy.

Conclusions:

• HOHA lactone causes significant mitochondrial dysfunction and oxidative stress in RPE cells.
• Histidyl hydrazide is a potent scavenger of HOHA lactone, mitigating RPE cell toxicity.
• HH derivatives show promise for treating HOHA lactone-related eye diseases like AMD.